Evolution of proteinuria after conversion from calcineurin inhibitors (CNI) to sirolimus (SRL) in renal transplant patients. A multicenter study

被引：0
|
作者：
Ruiz, JC
Diekmann, F
Campistol, JM
Sanchez-Fructuoso, A
Rivera, C
Oliver, J
Fernandez-Fresnedo, G
Arias, M
机构：
[1] Marques Valdecilla Univ Hosp, Santander, Spain
[2] Hosp Clin Barcelona, Renal Transplant Unit, Barcelona, Spain
[3] Hosp Clin Univ, Madrid, Spain
[4] Hosp Juan Canalejo, La Coruna, Spain
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
1426
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [31] The efficacy and limitations of sirolimus conversion in liver transplant patients who develop renal dysfunction on calcineurin inhibitors
    Lam, P
    Yoshida, A
    Brown, K
    Abouljoud, M
    Bajjoka, I
    Dagher, F
    Moonka, DK
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (06) : 1029 - 1035
  • [32] Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients
    van den Akker, J. M.
    Wetzels, J. F. M.
    Hoitsma, A. J.
    KIDNEY INTERNATIONAL, 2006, 70 (07) : 1355 - 1357
  • [33] Conversion from Calcineurin Inhibitor (CNI) to Sirolimus Versus Continued CNI in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficiency: Interim Safety and Efficacy Results
    Keogh, Anne
    Zuckermann, Andreas
    Crespo-Leiro, Maria G.
    Mancini, Donna
    Gonzalez-Vilchez, Francisco
    Almenar, Luis
    Brozena, Susan
    Eisen, Howard
    Tai, Sandi See
    Kushwaha, Sudhir
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 408 - 408
  • [34] Changes in Immunophenotypes After Conversion from Calcineurin Inhibitors to mTOR Inhibitors in Renal Transplant Recipients
    Yildiz, A.
    Cavusoglu, M.
    Adin, S.
    Caliskan, Y.
    Ozkok, A.
    Tasci, H.
    Deniz, G.
    Sariyar, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15
  • [35] Increase of proteinuria after conversion from calcineurin inhibitor to sirolimus-based treatment in kidney transplant patients with chronic allograft dysfunction
    Ruiz, Juan Carlos
    Campistol, Josep M.
    Sanchez-Fructuoso, Ana
    Rivera, Constantino
    Oliver, Juan
    Ramos, David
    Campos, Begona
    Arias, Manuel
    Diekmann, Fritz
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (11) : 3252 - 3257
  • [36] Conversion from calcineurin inhibitors to sirolimus improves renal function in heart transplant recipients with de novo renal dysfunction
    El-Hamamsy, I.
    Stevens, L. M.
    White, M.
    Perrault, L. P.
    Pellerin, M.
    Carrier, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S120 - S121
  • [37] Sirolimus (SRL) treatment in calcineurin-inhibitor (CNI) nephrotoxicity in heart transplantation: preliminary results of a multicenter registry in Spain (RAPACOR study)
    Crespo-Leiro, M. G.
    Delgado, J. F.
    Manito, N.
    Rabago, G.
    Lage, E.
    Arizon, J. M.
    Roig, E.
    Palomo, J.
    EUROPEAN HEART JOURNAL, 2005, 26 : 518 - 518
  • [38] Conversion from calcineurin inhibitors to sirolimus in transplant-associated thrombotic microangiopathy
    Kanunnikov, Mikhail M.
    Rakhmanova, Zhemal Z.
    Levkovsky, Nikita V.
    Vafina, Aliya I.
    Goloshapov, Oleg V.
    Shchegoleva, Tatiana S.
    Vlasova, Julia J.
    Paina, Olesya V.
    Morozova, Elena V.
    S. Zubarovskaya, Ludmilla
    Kulagin, Alexander D.
    S. Moiseev, Ivan
    CLINICAL TRANSPLANTATION, 2021, 35 (02)
  • [39] EARLY CONVERSION TO A CNI-FREE IMMUNOSUPPRESSION WITH SRL AFTER RENAL TX - LONGTERM DATA OF A MULTICENTER TRIAL
    Andrassy, Joachim
    Guba, Markus
    Habicht, Antje
    Pascher, Andreas
    Heller, Katharina
    Banas, Bernhard
    Hakenberg, Oliver
    Vogel, Thomas
    Werner, Jens
    Kauke, Teresa
    TRANSPLANT INTERNATIONAL, 2017, 30 : 63 - 63
  • [40] Sirolimus experience in liver transplant patients with renal insufficiency due to calcineurin inhibitors
    Meyer, C
    Lazzari, L
    Bonaccorsi, E
    Dervaux, T
    Ellero, B
    Woehl, ML
    Audet, M
    Jaeck, D
    Wolf, P
    JOURNAL OF HEPATOLOGY, 2004, 40 : 50 - 50
12345